Granulocytes in health and disease

2020 ◽  
pp. 5189-5197
Author(s):  
Joseph Sinning ◽  
Nancy Berliner

White cells (leucocytes) mediate inflammatory and immune responses and are key to the defence of the host against microbial pathogens. Subpopulations of leucocytes include granulocytes—neutrophils, eosinophils, and basophils; monocytes; and lymphocytes. Neutrophils comprise half the peripheral circulating leucocytes and are characterized by heterogeneous primary and secondary granules and a segmented nucleus. Maturation from the haematopoietic stem cell occurs in the bone marrow and takes 10 to 14 days. Neutrophilia—defined as an increase in the circulating neutrophil count to greater than 7.5 × 106/µl, usually occurs as an acquired reactive response to underlying disease. Causes include infection, particularly bacterial; drugs; malignancies, and hereditary conditions. Neutropenia—defined as a reduction in the absolute neutrophil count to less than 1.5 × 106/µl, is of particular importance because, when severe (<0.5 × 106/µl), it markedly increases the risk of life-threatening infection. Causes include drugs and toxins, postinfectious, nutritional deficiencies, autoimmune, large granular lymphocytosis, and congenital. Disorders of neutrophil function include chronic granulomatous disease, leucocyte adhesion deficiency, myeloperoxidase deficiency, and Chediak–Higashi syndrome. Monocytes share a common myeloid precursor with granulocytes, present antigens to T cells, produce several important cytokines with immunomodulatory and inflammatory functions, and are the precursors to resident tissue macrophages. They are especially important in defence against intracellular pathogens. Causes of monocytosis (>0.9 × 106/µl) include chronic infection, autoimmune diseases, and malignancy. Basophils are nonphagocytic granulocytes that function in immediate-type hypersensitivity. Basophilia (> 0.2 × 106/µl) is seen in myeloproliferative disorders, hypersensitivity reactions, and with some viral infections.

npj Vaccines ◽  
2021 ◽  
Vol 6 (1) ◽  
Author(s):  
Camille Zenobia ◽  
Karla-Luise Herpoldt ◽  
Marcelo Freire

AbstractMucosal tissues act as a barrier throughout the oral, nasopharyngeal, lung, and intestinal systems, offering first-line protection against potential pathogens. Conventionally, vaccines are applied parenterally to induce serotype-dependent humoral response but fail to drive adequate mucosal immune protection for viral infections such as influenza, HIV, and coronaviruses. Oral mucosa, however, provides a vast immune repertoire against specific microbial pathogens and yet is shaped by an ever-present microbiome community that has co-evolved with the host over thousands of years. Adjuvants targeting mucosal T-cells abundant in oral tissues can promote soluble-IgA (sIgA)-specific protection to confer increased vaccine efficacy. Th17 cells, for example, are at the center of cell-mediated immunity and evidence demonstrates that protection against heterologous pathogen serotypes is achieved with components from the oral microbiome. At the point of entry where pathogens are first encountered, typically the oral or nasal cavity, the mucosal surfaces are layered with bacterial cohabitants that continually shape the host immune profile. Constituents of the oral microbiome including their lipids, outer membrane vesicles, and specific proteins, have been found to modulate the Th17 response in the oral mucosa, playing important roles in vaccine and adjuvant designs. Currently, there are no approved adjuvants for the induction of Th17 protection, and it is critical that this research is included in the preparedness for the current and future pandemics. Here, we discuss the potential of oral commensals, and molecules derived thereof, to induce Th17 activity and provide safer and more predictable options in adjuvant engineering to prevent emerging infectious diseases.


Hematology ◽  
2016 ◽  
Vol 2016 (1) ◽  
pp. 43-50 ◽  
Author(s):  
Mary C. Dinauer

Abstract Immune deficiencies resulting from inherited defects in neutrophil function have revealed important features of the innate immune response. Although sharing an increased susceptibility to bacterial and fungal infections, these disorders each have distinctive features in their clinical manifestations and characteristic microbial pathogens. This review provides an update on several genetic disorders with impaired neutrophil function, their pathogenesis, and treatment strategies. These include chronic granulomatous disease, which results from inactivating mutations in the superoxide-generating nicotinamide dinucleotide phosphate oxidase. Superoxide-derived oxidants play an important role in the control of certain bacterial and fungal species, and also contribute to the regulation of inflammation. Also briefly summarized are updates on leukocyte adhesion deficiency, including the severe periodontal disease characteristic of this disorder, and a new immune deficiency associated with defects in caspase recruitment domain–containing protein 9, an adaptor protein that regulates signaling in neutrophils and other myeloid cells, leading to invasive fungal disease.


2005 ◽  
Vol 289 (1) ◽  
pp. L111-L124 ◽  
Author(s):  
Sabine Teske ◽  
Andrea A. Bohn ◽  
Jean F. Regal ◽  
Joshua J. Neumiller ◽  
B. Paige Lawrence

Unlike their role in bacterial infection, less is known about the role of neutrophils during pulmonary viral infection. Exposure to pollutant 2,3,7,8-tetrachlorodibenzo- p-dioxin (TCDD, dioxin) results in excess neutrophils in the lungs of mice infected with influenza A virus. TCDD is the most potent agonist for the aryl hydrocarbon receptor (AhR), and exposure to AhR ligands has been correlated with exacerbated inflammatory lung diseases. However, knowledge of the effects of AhR agonists on neutrophils is limited. Likewise, the factors regulating neutrophil responses during respiratory viral infections are not well characterized. To address these knowledge gaps, we determined the in vivo levels of KC, MIP-1α, MIP-2, LIX, IL-6, and C5a in infected mouse lungs. Our data show that these neutrophil chemoattractants are generally produced transiently in the lung within 12–24 h of infection. We also report that expression of CD11a, CD11b, CD49d, CD31, and CD38 is increased on pulmonary neutrophils in response to influenza virus. Using AhR-deficient mice, we demonstrate that excess neutrophilia in the lung is mediated by activation of the AhR and that this enhanced neutrophilia correlates directly with decreased survival in TCDD-exposed mice. Although AhR activation results in more neutrophils in the lungs, we show that this is not mediated by deregulation in levels of common neutrophil chemoattractants, expression of adhesion molecules on pulmonary neutrophils, or delayed death of neutrophils. Likewise, exposure to TCDD did not enhance pulmonary neutrophil function. This study provides an important first step in elucidating the mechanisms by which AhR agonists exacerbate pulmonary inflammatory responses.


2015 ◽  
Vol 40 (3) ◽  
pp. 298-301 ◽  
Author(s):  
Glen Davison ◽  
Arwel Wyn Jones

Neutrophil numbers and function (oxidative burst) were assessed in peripheral blood and oral samples before and after prolonged exercise. Blood neutrophil count increased (∼3.5-fold, P < 0.001) and function decreased (30% ± 19% decrease, P = 0.005) postexercise. Oral neutrophil count (P = 0.392) and function (P = 0.334) were unchanged. Agreement between oral and blood neutrophil function responses to exercise was poor. These findings highlight the importance of studying neutrophils within various compartments/sample types.


Author(s):  
I. Putu Eka Widyadharma ◽  
Putri Rossyana Dewi ◽  
Ida Ayu Sri Wijayanti ◽  
Desak Ketut Indrasari Utami

Abstract Pain is a common health problem all around the world. The pain symptoms are various depending on the underlying disease or the direct cause of pain itself. Viral infection could cause arthralgia or acute-onset arthritis, moreover in pandemic era of SARS-CoV-2 infection. The patients might experience arthritis, arthralgia, joint pain, or musculoskeletal pain. Viral infection including parvovirus B19, hepatitis virus, human immunodeficiency virus, arthropod-borne virus, and coronavirus could cause various types of pain. The pathogenesis of these symptoms is similar to each other despite of different causative organism. This review will discuss about pain caused by various causative organisms.


2021 ◽  
Vol 13 (4) ◽  
pp. 14-24
Author(s):  
N. N. Klimko ◽  
O. V. Shadrivova

Invasive aspergillosis is a life-threatening complication in patients with severe influenza and COVID-19 in intensive care units. Risk factors for the invasive aspergillosis development are transitory immunosuppression associated with severe influenza and COVID-19, as well as the use of glucocorticosteroids and immunosuppressive therapy. In the presence of risk factors, suspected clinical and radiological signs of invasive aspergillosis, bronchoscopy and examination of material from the lower respiratory tract are necessary: test for galactomannan, microscopy with white calcofluor staining and inoculation on Sabouraud agar medium. Voriconazole or are recommended as first-line treatment for invasive aspergillosis in patients with severe influenza and COVID-19. Amphotericin B Liposomal, Amphotericin B Lipid Complex, and Caspofungin are the alternative options for the invasive aspergillosis treatment. Combination therapy is possible. It is necessary to control the underlying disease with eliminate or reduce the severity of risk factors. 


2017 ◽  
Vol 86 (5-6) ◽  
Author(s):  
Marina Praprotnik ◽  
Melanija Županič ◽  
Tina Lozej ◽  
Uroš Krivec ◽  
Delovna skupina Za pediatrično pulmologijo

Cough is a common problem in children. Acute cough lasts less than 3 weeks, subacute 3–8 weeks and chronic cough more than 8 weeks.Acute cough is usually caused by common viral upper respiratory tract infection. However, the child should be thoroughly evaluated to rule out a serious underlying condition or disease responsible for the cough.The commonest cause of subacute cough is a viral infection (postinfectious cough) and it usually resolves spontaneously. If the child is otherwise well and the cough is dry and there are no specific alerts for a serious disease and the cough is resolving, a period of observation is all that is recommended. If there are any specific pointers in history and examination identified for an inhaled foreign body, chronic lung disease, or in a case of progressive cough, immediate investigations are needed.Most chronic coughs in childhood are due to viral infections, but may signify a serious underlying disease too. Chronic cough is subdivided into specific cough (i.e., cough associated with other symptoms and signs suggestive of an associated or underlying problem) and nonspecific cough (i.e., dry cough in the absence of an identifiable respiratory disease of known etiology).To prevent unnecessary investigations and ineffective treatment, and at the same time not to overlook a severe underlying disease, cough guidelines have been designed which are based on evidencebased medicine.


Author(s):  
S.M. Tsvirenko ◽  
N.S. Artiomova ◽  
O.I. Ananevych ◽  
I.I. Adruschenko ◽  
O.V. Bеlan

According to WHO, acute respiratory diseases are at the forefront of the incidence rate of infants and are among the most common diseases due to which children are hospitalized. The aim of the research was to analyze the structure of morbidity and features of the course in acute respiratory diseases in infants with the study of the frequency of leading nosological forms that required inpatient treatment. A retrospective analysis of the medical records of inpatients (3845 children), treated during 2016-2018 was conducted. The study found that there is a tendency for an increase in the number of infants who require inpatient treatment, as well as an increased number of nosologies in the treated children. As the underlying disease, the first place in the structure of the morbidity belonged to acute respiratory viral infections. In the dynamics of the studied years, an increase in the frequency of acute obstructive bronchitis was noted. This pathology has the second place in the structure of morbidity among hospitalized children. The permanent third place in the structure of nosologies belongs to acute pneumonia. The premorbid background of most children with bronchial obstruction syndrome and acute community-acquired pneumonia was aggravated. The most commonly determined disorders were I-II degree anemia, overweight, impaired calcium metabolism, aggravated allergic history, transient immune deficiency. Conclusions. Our analysis of the structure of acute respiratory pathology in infants who required inpatient treatment showed that in the dynamics of 2016-2018, there was an increase in cases of acute obstructive bronchitis and acute community-acquired pneumonia. The study of general structure of nosologies in children treated at the inpatient department revealed an increase in their number and a tendency for the formation of comorbid pathology in infants.


Sign in / Sign up

Export Citation Format

Share Document